Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,726,953
+$1,582,260 QoQ
Shares Held
3,941
+15.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,757
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hills Bank & Trust Co holds $20,137,806 across 12 Drug Manufacturers - General names. LLY ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
34,221 | $8,691,106 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
3,941 | $4,726,953 | |
| 3 | ABBV |
AbbVie Inc.
|
7,303 | $1,837,726 | |
| 4 | GSK |
GSK plc
|
17,496 | $917,140 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
15,545 | $895,702 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,571 | $844,373 | |
| 7 | BIIB |
Biogen Inc.
|
3,088 | $667,193 | |
| 8 | PFE |
Pfizer Inc
|
24,108 | $580,519 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,726,953 | 3,941 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $3,144,693 | 3,419 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $3,414,258 | 3,177 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $2,274,503 | 2,981 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,439,149 | 3,129 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,637,955 | 3,194 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $2,635,608 | 3,414 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $3,317,844 | 3,745 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $3,064,710 | 3,385 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,601,498 | 3,344 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $1,833,283 | 3,145 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $1,812,276 | 3,374 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $2,009,578 | 4,285 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $1,591,064 | 4,633 | Shares | Defined | 2023-04-17 | |
| 2022-12-31 | $1,909,684 | 5,220 | Shares | Defined | 2023-02-06 | |
| 2022-09-30 | $1,916,494 | 5,927 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $2,293,602 | 7,074 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $2,250,008 | 7,857 | Shares | Defined | 2022-08-16 | |
| 2021-12-31 | $2,161,973 | 7,827 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,753,900 | 7,591 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,605,033 | 6,993 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,300,454 | 6,961 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,144,397 | 6,778 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $935,338 | 6,319 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $819,094 | 4,989 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $644,908 | 4,649 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||